Page last updated: 2024-08-21

adamantane and Leukemia, Lymphocytic, T Cell

adamantane has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avramis, IA; Avramis, VI; Christodoulopoulos, G; Gonzalez-Gomez, I; Laug, WE; McNamara, G; Sausville, EA; Suzuki, A1

Other Studies

1 other study(ies) available for adamantane and Leukemia, Lymphocytic, T Cell

ArticleYear
In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
    Cancer chemotherapy and pharmacology, 2002, Volume: 50, Issue:6

    Topics: Adamantane; Animals; Blotting, Western; Brain Neoplasms; Caspase 3; Caspases; DNA, Neoplasm; Drug Resistance, Neoplasm; Endothelial Growth Factors; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix Proteins; Female; Fusion Proteins, bcr-abl; Glioblastoma; Humans; Hydroquinones; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Leukemia, T-Cell; Lymphokines; Mice; Mice, Nude; Myosin Heavy Chains; Neoplasm Transplantation; Nonmuscle Myosin Type IIB; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors

2002